The Efficacy and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia
Clinical trial NCT05551221 · COMPLETED
Trial details
- NCT number
- NCT05551221
- Sponsor
- Xintian Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-18
- Primary completion
- 2024-09-10
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.